C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
01/2003
01/02/2003	US20030003396 Reflection, protective or covering layers which can be written on or read by blue, red or infrared light
01/02/2003	EP1270576A2 3-phenyl-3,7-diazabicyclo[3,3,1]nonanes, process for their preparation and pharmaceutical compositions containing them
01/02/2003	EP1270549A1 Polymer-immobilized alpha-iminoester
01/02/2003	EP1268431A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
01/02/2003	EP1268425A2 Carbamate caspase inhibitors and uses thereof
01/02/2003	EP0804431B9 GLYCOPROTEIN IIb/IIIa ANTAGONISTS
01/01/2003	CN1388119A Stereoselective preparation for chirality 1-aryl-and 1-heteroaryl-2-substituted-ethyl-2-amine
12/2002
12/31/2002	US6500855 Nitrogen containing aromatic heterocycles with ortho-substituted p1 groups; anticoagulants
12/31/2002	US6500819 Has an excellent anxiolytic effect
12/27/2002	WO2002102803A1 Total synthesis of galanthamine, analogues and derivatives thereof
12/26/2002	US20020198386 Lactam-aldehyde compound and process of preparing same
12/26/2002	US20020198385 Dimeric non-azo naphthalimides and uses for same
12/26/2002	US20020198216 Novel farnesyl protein transferase inhibitors as antitumor agents
12/26/2002	US20020198207 Novel Hexanoic acid derivatives
12/26/2002	US20020197561 Information layer comprises a light-absorbent compound that is a dye which cyclizes thermally
12/26/2002	US20020197439 Optical data storage medium containing a triazacyanine dye as the light-absorbing compound in the information layer
12/24/2002	US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same
12/24/2002	US6498162 Treating inflammatory and allergic diseases of respiratory tract and diseases of central nervous system
12/19/2002	WO2002080161A3 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
12/19/2002	US20020193602 Opioid receptor antagonists and agonists; for example, a 1-(arylcarbonylaminoalkyl),3,4-dimethyl-4-(3-hydroxyphenyl)-piperidine compound of given formula
12/19/2002	US20020193578 Compounds having activity as inhibitors of cytochrome P450RAI
12/19/2002	US20020193360 For enhancing cognition or in the treatment of diseases of cognitive dysfunction including but not limited to Alzheimer's Disease (AD), mild cognitive impairment, age-related cognitive decline, vascular dementia, Parkinson's disease
12/19/2002	US20020193354 7, 9-substituted tetracycline compounds
12/19/2002	US20020193291 Treating NIDDM with RXR agonists
12/19/2002	DE10115227A1 Optischer Datenträger enthaltend in der Informationsschicht eine lichtabsorbierende Verbindung mit mehreren chromophoren Zentren Optical data storage medium in the information layer containing a light absorbing compound having a plurality of chromophoric centers
12/18/2002	EP1266899A2 Rapamycin hdroxyesters, process for their preparation and pharmaceutical compositions containing them
12/18/2002	EP1265609A1 Methods for treating sexual dysfunction with apomorphine at specified plasma concentration levels
12/17/2002	US6495690 By reacting cyclic ketones with aliphatic aldehyde in presence of ammonia in gaseous phase in presence of catalyst
12/17/2002	US6495689 Synthesis of intermediates useful in preparing tricyclic compounds
12/17/2002	US6495559 For therapy of obesity
12/17/2002	US6495552 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid.
12/17/2002	US6495541 Tricyclic inhibitors of poly(ADP-ribose) polymerases
12/17/2002	CA2204616C Ppar gamma antagonists for treating obesity
12/12/2002	WO2002098854A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002	CA2449813A1 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/11/2002	EP1263733A2 Derivatives of quinoline as alpha-2 antagonists
12/10/2002	US6492519 Chemical intermediate for antihistamine
12/10/2002	US6492517 The present invention relates to a method for preparing 5- and 6-halomethyl quinoxalines in presence of a radical initiator in a solvent selected from the group consisting of fluorobenzene, difluorobenzenes, trifluorobenzenes,
12/10/2002	US6492390 Treating cyclooxygenase-2 mediated disorders.
12/10/2002	US6492381 Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
12/10/2002	US6492380 Method of inhibiting neurotrophin-receptor binding
12/10/2002	US6492378 Substituted isoquinoline derivatives and their use as anticonvulsivants
12/10/2002	CA2057604C Process for producing an aryl-imido-peralkanoic acid
12/05/2002	US20020183350 Phenanthridine-n-oxides with pde-iv inhibiting activity
12/05/2002	US20020183326 1,2,4-triazolo[4,3-B]pyrido[3,2-D]pyridazine derivatives and pharmaceutical compositions containing them
12/04/2002	EP1262479A1 Lactam-aldehyde compound and process of preparing same
12/03/2002	US6489478 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines
12/03/2002	US6489352 Antiepileptic agents; nervous system disorders
12/03/2002	CA2065644C Pyrazolopyridine compound and processes for preparation thereof
11/2002
11/27/2002	EP1259489A1 Aryl fused azapolycyclic compounds
11/27/2002	EP1259236A1 Tyrosine kinase inhibitors
11/27/2002	EP1000035B1 Substituted 6-phenylphenanthridines
11/26/2002	US6486324 Forming libraries of bactericides; immobilization; side effect reduction
11/26/2002	US6486319 Thermochromic rylene dyes
11/26/2002	US6486173 Serotonin-7 (5-ht7); treatment of central nervous system disorders such as sleep disorders, depression and schizophrenia; for example 1,3-dihydro-2-((4-(4-fluorophenyl)-4-oxobutyl))isoindole
11/26/2002	US6486167 Heterocyclic cytotoxic agents
11/21/2002	WO2002092597A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.0?2,11.04.9¿)-hexadeca-2.(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002	WO2002092089A1 Tartrate salts of 5,8,14-triazatetracyclo {10.3.1.0?2,11.04,9¿}-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002	WO2002092076A1 Substituted coumarins and quinolines as caspases activators
11/21/2002	WO2002091830A1 Pyridinyl fused bicyclic amide as fungicides
11/21/2002	WO2002053528A8 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines
11/21/2002	US20020173651 By reacting cyclic ketones with aliphatic aldehyde in presence of ammonia in gaseous phase in presence of catalyst
11/21/2002	US20020172793 Optical data store comprising an axially substituted cobalt phthalocyanine in the light-writeable information layer
11/21/2002	CA2446988A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.02,11.04.9)-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/20/2002	EP1258244A1 High affinity ligands for nociceptin receptor ORL-1
11/14/2002	WO2002024650B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/14/2002	US20020169324 N-substituted(+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine compounds; opiod receptors
11/14/2002	US20020169182 Neurotrophin antagonist compositions
11/13/2002	EP1256353A1 Remedies for sjoegren's syndrome
11/13/2002	EP1112272B1 Muscarinic agonists and antagonists
11/13/2002	CN1379769A Novel composition and method or stabilizing same
11/12/2002	US6479505 6-arylphenanthridines with PDE-IV inhibiting activity
11/12/2002	US6479503 Cycloalkano-indole and -azaindole derivatives
11/12/2002	US6479501 Cognition activators; antidepressants
11/07/2002	WO2002089128A1 An optical data storage medium containing a diaza hemicyanine dye as the light-absorbing compound in the information layer
11/07/2002	US20020165396 Novel opiate compounds, methods of making and methods of use
11/07/2002	US20020165252 Such as methyl-2-cyclopentyl-4-(4-fluorophenyl)-5-oxo-7,7-dimethyl-1,4,5,6,7,8 -hexahydroquinoline-3-carboxylate for treatment of arteriosclerosis and dyslipidaemias; condensation
11/06/2002	EP1254118A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/06/2002	CN1378535A 四氢喹啉衍生物 Tetrahydroquinoline derivative
11/05/2002	US6476048 Substituted phenanthridinones and methods of use thereof
11/05/2002	US6476025 Phenylphennanthridines with PDE-IV inhibiting activity
11/05/2002	US6476022 Oxathiepino[6,5-b]dihydropyridines, and related compositions and methods
10/2002
10/31/2002	WO2002086879A1 Optical data support comprising a hemicyanin dye in the information layer as light-absorbing compound
10/31/2002	WO2002086878A2 Optical data carrier whose information layer contains a light-absorbing compound having a number of chromophoric centers
10/31/2002	WO2002085894A1 Arylindenopyridines with pde inhibiting activity
10/31/2002	WO2002085843A2 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/31/2002	WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002	WO2002085354A1 Spiroindene and spiroindane compounds
10/31/2002	WO2002069895A3 Heterocyclic analgesic compounds and methods of use thereof
10/31/2002	WO2002068538A3 Thermochromic rylene dyes
10/31/2002	WO2002044416A3 Sulfonated diarylrhodamine dyes as fluorescent labels
10/31/2002	WO2001070675A3 Inhibitors of histone deacetylase
10/31/2002	US20020160984 For example, 2,3-dihydro-1H-benz(de)isoquinolin-1-one; treating diabetes, cancer, radiosensitizing tumor cells, cardiovascular disorders, septic shock, inflammatory bowel disease, senescent cells
10/31/2002	CA2445188A1 Arylindenopyridines with pde inhibiting activity
10/31/2002	CA2443946A1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/29/2002	US6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
10/29/2002	US6472405 Glycoprotein IIB/IIIA antagonists
10/24/2002	WO2002084656A1 Optical data carrier that contains a triazacyanine dye as the light-absorbing compound in the information layer g
10/24/2002	WO2002030931A3 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
10/24/2002	US20020156050 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors

1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 110